Mega Lifesciences Public Company Limited
MEGA
Rank in Stocks
#9083
Established in Bangkok, Thailand, in 1982, Mega Lifesciences Public Company... Established in Bangkok, Thailand, in 1982, Mega Lifesciences Public Company Limited, a subsidiary of Unistretch Limited, operates as a comprehensive pharmaceutical and wellness enterprise. Its primary activities encompass the development, promotion, and distribution of a broad spectrum of health-related products, including nutritional supplements, prescription medicines, over-the-counter (OTC) remedies, botanical solutions, vitamins, and everyday consumer goods. The company structures its operations across three main divisions: Brands, Distribution, and Original Equipment Manufacture. Mega Lifesciences offers an extensive array of complementary medicines targeting various health concerns such as bone and joint health, pediatric care, diabetes management, cardiovascular support, digestive and liver wellness, skin health, weight management, overall well-being, men's and women's specific needs, and sports nutrition. Its OTC portfolio addresses common issues like gastrointestinal discomfort and pain. Furthermore, the prescription drug division covers crucial therapeutic areas including iron deficiency, anticoagulation, diabetology, cardiology, dermatology, gastroenterology, neurology, pain relief, osteoporosis, respiratory conditions, urology, oncology, and nephrology. Beyond its proprietary product lines, the company also provides third-party logistical and marketing services. Additionally, Mega Lifesciences is involved in managing wellness centers and offers specialized services in software design, development, and related technological solutions. The company maintains a significant global footprint, with operations spanning the Asia Pacific region, the Middle East, Africa, and the Commonwealth of Independent States.
Share Price
$1.05
Last synced: 2026-11-10
Market Cap
$913.76M
Change (1 day)
-1.41%
Change (1 year)
14.03%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Mega Lifesciences Public Company Limited (MEGA)
Category
Healthcare
Dividend yield history for Mega Lifesciences Public Company Limited (MEGA)
Mega Lifesciences Public Company Limited (stock symbol: MEGA) dividend yield (TTM) as of 2025: 4.78%
Average dividend yield, last 5 years : 3.82%
Average dividend yield, last 5 years : 3.82%
Dividend yield history for Mega Lifesciences Public Company Limited (MEGA) from 2010 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 5.00% | 4.60% |
| 2025 | 4.78% | -0.83% |
| 2024 | 4.82% | 22.03% |
| 2023 | 3.95% | 14.49% |
| 2022 | 3.45% | 64.29% |
| 2021 | 2.10% | -2.33% |
| 2020 | 2.15% | -21.25% |
| 2019 | 2.73% | 11.43% |
| 2018 | 2.45% | 99.19% |
| 2017 | 1.23% | -33.87% |
| 2016 | 1.86% | -25.00% |
| 2015 | 2.48% | 46.75% |
| 2014 | 1.69% | -71.64% |
| 2013 | 5.96% | 540.86% |
| 2012 | 0.93% | 55.00% |
| 2011 | 0.60% | 0.00% |
| 2010 | 0.00% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 1.63% |
DE
|
|
| 1.45% |
DE
|
|
| 3.04% |
JP
|
|
| 0.18% |
CH
|
|
| 0.00% |
IL
|
Questions about Mega Lifesciences Public Company Limited's dividend yield
What is Mega Lifesciences Public Company Limited's dividend yield?
Mega Lifesciences Public Company Limited's dividend yield is 5.00%, as of Nov 2026.
What was Mega Lifesciences Public Company Limited's dividend yield in 2025?
In 2025, Mega Lifesciences Public Company Limited's dividend yield was 4.78%, compared with 4.82% in 2024.
How has Mega Lifesciences Public Company Limited's dividend yield changed since 2020?
From 2020 to 2025, Mega Lifesciences Public Company Limited's dividend yield was highest in 2024 (4.82%) and lowest in 2021 (2.10%).
How does Mega Lifesciences Public Company Limited's dividend yield compare with similar companies?
Mega Lifesciences Public Company Limited's dividend yield (5.00%) is higher than that of all 5 similar companies listed above. The highest among them is Takeda Pharmaceutical Company Limited, with 3.04%.